China License Out

Announced Date: 2025-08-19 (August 19, 2025) Asset Name: RC28-E Intravitreal Injection Licensor: RemeGen (RemeGen Co., Ltd., … [China BD Deal] RemeGen and Santen enters a 1.3 billion RMB license on Anti-VEGF/FGF Fusion Protein RC28-ERead more

Announced Date: 2025-08-11 (August 11, 2025) Asset Name: XH-S004 Licensor: Shanghai Fosun Pharmaceutical (Group) Co., Ltd. … [China BD Deal] Fosun and Expedition achieved a 645 million license on DPP-1 i XH-S004Read more

Announced Date: 2025-07-30 (JULY 30, 2025) Asset Name: SYH2086 Licensor: CSPC Pharmaceutical Group Limited (HKEX Stock … [China BD Deal] CSPC and Madrigal achieved a 2 billion license on GLP-1 R SYH2086Read more

Announced Date: 2025-07-28 (JULY 28, 2025) Asset Name: HRS-9821 and other 11 preclinical medicines Licensor: Hengrui … [China BD 2025] Hengrui and GSK  achieved a 12.5 billion USD license on PDE3/4 inhibitor HRS-9821 and 11 other assetsRead more

Announced Date: 2025-05-19 (May 19, 2025), 2025-07-24 updated Asset Name: SSGJ-707 Licensor: 3SBio, Inc (01530.HK) (Headquarter Shanghai … [China BD Deal] 3SBio and Pfizer Completes a 6 billion License on PD-1/VEGF BsAbs SSGJ-707Read more

Announced Date: 2025-06-26 (June 26, 2025) Asset Name: 9MW3811 Licensor: Mabwell (Shanghai) Bioscience (China) Licensee (Buyer): … [China BD 2025] Mabwell Bioscience and Calico Life Sciences Enters a 596 million USD License for IL-11 Targeting Monoclonal Antibody 9MW3811Read more

Announced Date: 2025-06-22 (June 22, 2025) Asset Name: HBM7020 Licensor (Seller): Harbour BioMed (China) Licensee (Buyer): … [China BD 2025] Harbour BioMed and Otsuka enters a 670 million USD License on BCMAxCD3 bispecific T-cell engager HBM7020Read more

Announced Date: 2025-06-03 (June 3, 2025) Asset Name: ITG-1052 (Lenamilast) Licensor: Suzhou Intragrand Pharma (China) Licensee … [China BD 2025] Intragrand and Transpire enters a license on PDE4 inhibitor ITG-1052Read more

Announced Date: 2025-06-02 (June 2, 2024) Asset Name: HS-20094 Licensor: Hansoh (Hansoh Pharmaceuticals Group, China) Licensee … [China BD deal 2025]Hansoh and Regeneron enters a 2 billion USD license on GLP-1/GIP Ra HS-20094Read more

Announced Date: 2025-05-29 (May 29, 2025) Asset Name: XNW27011 Licensor: Evopoint (Evopoint Biosciences Co., Ltd., China) Licensee … [China BD 2025] Evopoint and Astellas enters a 1.54 billion USD license on CLDN18.2 ADC XNW27011Read more